New eye lens aims to sharpen Mid-Range sight after cataracts

NCT ID NCT06479148

Terminated Disease control Sponsor: Bausch & Lomb Incorporated Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new type of artificial lens (enVista Aspire) for people having cataract surgery. The goal was to see if it improves intermediate vision, like seeing a computer screen, better than standard lenses. The trial was stopped early and included 27 adults aged 22 and older.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: enVista Aspire intraocular lens (a device implanted in the eye during cataract surgery)
What this could lead to: If successful, this lens could improve intermediate vision (e.g., seeing a computer screen) after cataract surgery, reducing the need for glasses.
What could go wrong: The trial was terminated early with only 27 participants, so results are limited. Risks include standard cataract surgery complications like infection or inflammation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT

Contacts and locations

Locations

Site 101 Centro Oftalmológico Robles

Santa Rosa de Copán, Copán Department, 41101, Honduras

More trials for these conditions

Other studies related to the condition(s) this trial covers.